Table: begin end state 1 25 signal peptide 26 39 non-cytoplasmic 40 60 transmembrane 61 80 cytoplasmic 81 98 transmembrane 99 108 non-cytoplasmic 109 129 transmembrane 130 133 cytoplasmic 134 153 transmembrane 154 158 non-cytoplasmic 159 177 transmembrane 178 183 cytoplasmic 184 200 transmembrane 201 249 non-cytoplasmic 250 270 transmembrane 271 303 cytoplasmic 304 323 transmembrane 324 338 non-cytoplasmic 339 366 transmembrane 367 374 cytoplasmic 375 392 transmembrane 393 408 non-cytoplasmic
Input: >HSERO_RS08280 HSERO_RS08280 leucine/isoleucine/valine transporter permease subunit MPETFKNAVTAALVTAVLTIPLLGMQLQLEGYRVVLNTHWTPVLVAVLAVFLFQLAKPVL SRSSAGIKLPALPRMQPRQQRAAVMILLMAALVWPFFGSRGYVDVMTLALIYVVLGLGLN IVVGFAGLLDLGYVGFYAVGAYTYALCNQYFGLTFWECVPLAAAASALFGFLLGFPVLRL RGDYLAIVTLGFGEIIRLLLNNMTSITGGPDGVSGIPKPTVFGLVMARNPVTEGGTTFHQ LFGLSYQGGHMVIFLYFLALLMVLFTYFVTSRLLRMPMGRAWEALREDEIACRSLGINPT KVKLSAFTLGAAFAGLAGSFFAARQGLVTPESFTFIESALILAIVVLGGMGSQLGVILAA ILLTVLPELARSFAEYRMLIFGLVMVLMMMWRPQGLLPATRPHVELPQ
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server